Pediatric	O
Hypovitaminosis	B:C0042870
D	I:C0042870
:	O
Molecular	O
Perspectives	O
and	O
Clinical	O
Implications	O
Vitamin	O
D	I:C0042866
,	O
a	O
secosteroid	O
,	O
is	O
essential	O
for	O
the	O
development	O
and	O
maintenance	O
of	O
healthy	O
bone	O
in	O
both	O
the	O
adult	O
and	O
pediatric	O
populations	O
.	O

Pediatric	O
Hypovitaminosis	O
D	I:C0042870
:	O
Molecular	O
Perspectives	O
and	O
Clinical	O
Implications	O
Vitamin	B:C0042866
D	I:C0042866
,	O
a	O
secosteroid	O
,	O
is	O
essential	O
for	O
the	O
development	O
and	O
maintenance	O
of	O
healthy	O
bone	O
in	O
both	O
the	O
adult	O
and	O
pediatric	O
populations	O
.	O

Pediatric	O
Hypovitaminosis	O
D	I:C0042870
:	O
Molecular	O
Perspectives	O
and	O
Clinical	O
Implications	O
Vitamin	O
D	I:C0042866
,	O
a	O
secosteroid	B:C0036532
,	O
is	O
essential	O
for	O
the	O
development	O
and	O
maintenance	O
of	O
healthy	O
bone	O
in	O
both	O
the	O
adult	O
and	O
pediatric	O
populations	O
.	O

Pediatric	O
Hypovitaminosis	O
D	I:C0042870
:	O
Molecular	O
Perspectives	O
and	O
Clinical	O
Implications	O
Vitamin	O
D	I:C0042866
,	O
a	O
secosteroid	O
,	O
is	O
essential	O
for	O
the	O
development	B:C0678723
and	O
maintenance	O
of	O
healthy	O
bone	O
in	O
both	O
the	O
adult	O
and	O
pediatric	O
populations	O
.	O

Pediatric	O
Hypovitaminosis	O
D	I:C0042870
:	O
Molecular	O
Perspectives	O
and	O
Clinical	O
Implications	O
Vitamin	O
D	I:C0042866
,	O
a	O
secosteroid	O
,	O
is	O
essential	O
for	O
the	O
development	O
and	O
maintenance	O
of	O
healthy	O
bone	B:C0262950
in	O
both	O
the	O
adult	O
and	O
pediatric	O
populations	O
.	O

Pediatric	O
Hypovitaminosis	O
D	I:C0042870
:	O
Molecular	O
Perspectives	O
and	O
Clinical	O
Implications	O
Vitamin	O
D	I:C0042866
,	O
a	O
secosteroid	O
,	O
is	O
essential	O
for	O
the	O
development	O
and	O
maintenance	O
of	O
healthy	O
bone	O
in	O
both	O
the	O
adult	O
and	O
pediatric	O
populations	B:C1257890
.	O

Low	O
level	O
of	O
25	B:C0006657
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	B:C0006657
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	B:C0879626
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	B:C0035579
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	B:C0029442
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	B:C0410213
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	B:C0872084
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	B:C3714552
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	B:C0151686
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	B:C0020598
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	B:C0036572
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	B:C0039621
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	B:C0004352
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	B:C0007222
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	B:C0011849
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	B:C0006826
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	B:C0376358
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	B:C0009375
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	B:C0006142
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	B:C0009450
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	B:C0042769
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	B:C0041296
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	B:C0004364
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	B:C0026769
sclerosis	I:C0026769
and	O
Hashimoto	O
's	I:C0677607
thyroiditis	I:C0677607
.	O

Low	O
level	O
of	O
25	O
-	I:C0006657
hydroxy	I:C0006657
vitamin	I:C0006657
D	I:C0006657
(	O
25	O
-	I:C0006657
(	I:C0006657
OH	I:C0006657
)	I:C0006657
-	I:C0006657
D	I:C0006657
)	O
is	O
highly	O
prevalent	O
in	O
children	O
worldwide	O
and	O
has	O
been	O
linked	O
to	O
various	O
adverse	O
health	O
outcomes	O
including	O
rickets	O
,	O
osteomalacia	O
,	O
osteomalacic	O
myopathy	I:C0410213
,	O
sarcopenia	O
,	O
and	O
weakness	O
,	O
growth	O
retardation	I:C0151686
,	O
hypocalcemia	O
,	O
seizure	O
and	O
tetany	O
,	O
autism	O
,	O
cardiovascular	O
diseases	I:C0007222
,	O
diabetes	O
mellitus	I:C0011849
,	O
cancers	O
(	O
prostate	O
,	O
colon	O
,	O
breast	O
)	O
,	O
infectious	O
diseases	I:C0009450
(	O
viral	O
,	O
tuberculosis	O
)	O
,	O
and	O
autoimmune	O
diseases	I:C0004364
,	I:C0004364
such	O
as	O
multiple	O
sclerosis	I:C0026769
and	O
Hashimoto	B:C0677607
's	I:C0677607
thyroiditis	I:C0677607
.	O

Risk	B:C0035648
factors	I:C0035648
for	O
hypovitaminosis	O
D	I:C0042870
are	O
people	O
with	O
darker	O
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	O
,	O
living	O
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	O
,	O
obesity	O
,	O
exclusive	O
breastfeeding	O
,	O
low	O
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	O
,	O
drinking	O
unfortified	O
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	O
failure	I:C0085605
,	O
chronic	O
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	O
fibrosis	I:C0010674
,	O
asthma	O
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

Risk	O
factors	I:C0035648
for	O
hypovitaminosis	B:C0042870
D	I:C0042870
are	O
people	O
with	O
darker	O
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	O
,	O
living	O
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	O
,	O
obesity	O
,	O
exclusive	O
breastfeeding	O
,	O
low	O
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	O
,	O
drinking	O
unfortified	O
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	O
failure	I:C0085605
,	O
chronic	O
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	O
fibrosis	I:C0010674
,	O
asthma	O
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

Risk	O
factors	I:C0035648
for	O
hypovitaminosis	O
D	I:C0042870
are	O
people	B:C0027361
with	O
darker	O
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	O
,	O
living	O
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	O
,	O
obesity	O
,	O
exclusive	O
breastfeeding	O
,	O
low	O
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	O
,	O
drinking	O
unfortified	O
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	O
failure	I:C0085605
,	O
chronic	O
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	O
fibrosis	I:C0010674
,	O
asthma	O
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

Risk	O
factors	I:C0035648
for	O
hypovitaminosis	O
D	I:C0042870
are	O
people	O
with	O
darker	B:C0037290
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	O
,	O
living	O
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	O
,	O
obesity	O
,	O
exclusive	O
breastfeeding	O
,	O
low	O
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	O
,	O
drinking	O
unfortified	O
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	O
failure	I:C0085605
,	O
chronic	O
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	O
fibrosis	I:C0010674
,	O
asthma	O
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

Risk	O
factors	I:C0035648
for	O
hypovitaminosis	O
D	I:C0042870
are	O
people	O
with	O
darker	O
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	B:C0021294
,	O
living	O
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	O
,	O
obesity	O
,	O
exclusive	O
breastfeeding	O
,	O
low	O
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	O
,	O
drinking	O
unfortified	O
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	O
failure	I:C0085605
,	O
chronic	O
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	O
fibrosis	I:C0010674
,	O
asthma	O
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

Risk	O
factors	I:C0035648
for	O
hypovitaminosis	O
D	I:C0042870
are	O
people	O
with	O
darker	O
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	O
,	O
living	B:C0337646
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	O
,	O
obesity	O
,	O
exclusive	O
breastfeeding	O
,	O
low	O
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	O
,	O
drinking	O
unfortified	O
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	O
failure	I:C0085605
,	O
chronic	O
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	O
fibrosis	I:C0010674
,	O
asthma	O
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

Risk	O
factors	I:C0035648
for	O
hypovitaminosis	O
D	I:C0042870
are	O
people	O
with	O
darker	O
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	O
,	O
living	O
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	B:C0162429
,	O
obesity	O
,	O
exclusive	O
breastfeeding	O
,	O
low	O
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	O
,	O
drinking	O
unfortified	O
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	O
failure	I:C0085605
,	O
chronic	O
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	O
fibrosis	I:C0010674
,	O
asthma	O
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

Risk	O
factors	I:C0035648
for	O
hypovitaminosis	O
D	I:C0042870
are	O
people	O
with	O
darker	O
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	O
,	O
living	O
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	O
,	O
obesity	B:C0028754
,	O
exclusive	O
breastfeeding	O
,	O
low	O
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	O
,	O
drinking	O
unfortified	O
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	O
failure	I:C0085605
,	O
chronic	O
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	O
fibrosis	I:C0010674
,	O
asthma	O
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

Risk	O
factors	I:C0035648
for	O
hypovitaminosis	O
D	I:C0042870
are	O
people	O
with	O
darker	O
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	O
,	O
living	O
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	O
,	O
obesity	O
,	O
exclusive	O
breastfeeding	O
,	O
low	B:C0243095
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	O
,	O
drinking	O
unfortified	O
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	O
failure	I:C0085605
,	O
chronic	O
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	O
fibrosis	I:C0010674
,	O
asthma	O
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

Risk	O
factors	I:C0035648
for	O
hypovitaminosis	O
D	I:C0042870
are	O
people	O
with	O
darker	O
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	O
,	O
living	O
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	O
,	O
obesity	O
,	O
exclusive	O
breastfeeding	O
,	O
low	O
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	B:C0013227
,	O
drinking	O
unfortified	O
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	O
failure	I:C0085605
,	O
chronic	O
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	O
fibrosis	I:C0010674
,	O
asthma	O
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

Risk	O
factors	I:C0035648
for	O
hypovitaminosis	O
D	I:C0042870
are	O
people	O
with	O
darker	O
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	O
,	O
living	O
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	O
,	O
obesity	O
,	O
exclusive	O
breastfeeding	O
,	O
low	O
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	O
,	O
drinking	B:C0684271
unfortified	O
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	O
failure	I:C0085605
,	O
chronic	O
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	O
fibrosis	I:C0010674
,	O
asthma	O
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

Risk	O
factors	I:C0035648
for	O
hypovitaminosis	O
D	I:C0042870
are	O
people	O
with	O
darker	O
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	O
,	O
living	O
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	O
,	O
obesity	O
,	O
exclusive	O
breastfeeding	O
,	O
low	O
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	O
,	O
drinking	O
unfortified	B:C0349374
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	O
failure	I:C0085605
,	O
chronic	O
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	O
fibrosis	I:C0010674
,	O
asthma	O
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

Risk	O
factors	I:C0035648
for	O
hypovitaminosis	O
D	I:C0042870
are	O
people	O
with	O
darker	O
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	O
,	O
living	O
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	O
,	O
obesity	O
,	O
exclusive	O
breastfeeding	O
,	O
low	O
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	O
,	O
drinking	O
unfortified	O
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	B:C0085605
failure	I:C0085605
,	O
chronic	O
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	O
fibrosis	I:C0010674
,	O
asthma	O
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

Risk	O
factors	I:C0035648
for	O
hypovitaminosis	O
D	I:C0042870
are	O
people	O
with	O
darker	O
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	O
,	O
living	O
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	O
,	O
obesity	O
,	O
exclusive	O
breastfeeding	O
,	O
low	O
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	O
,	O
drinking	O
unfortified	O
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	O
failure	I:C0085605
,	O
chronic	B:C0403447
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	O
fibrosis	I:C0010674
,	O
asthma	O
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

Risk	O
factors	I:C0035648
for	O
hypovitaminosis	O
D	I:C0042870
are	O
people	O
with	O
darker	O
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	O
,	O
living	O
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	O
,	O
obesity	O
,	O
exclusive	O
breastfeeding	O
,	O
low	O
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	O
,	O
drinking	O
unfortified	O
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	O
failure	I:C0085605
,	O
chronic	O
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	B:C0010674
fibrosis	I:C0010674
,	O
asthma	O
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

Risk	O
factors	I:C0035648
for	O
hypovitaminosis	O
D	I:C0042870
are	O
people	O
with	O
darker	O
skin	I:C0037290
pigmentation	I:C0037290
,	O
use	O
of	O
sunscreen	O
,	O
insufficient	O
ultraviolet	O
B	O
exposure	O
,	O
prematurity	O
,	O
living	O
in	I:C0337646
northern	I:C0337646
latitudes	I:C0337646
,	O
malnutrition	O
,	O
obesity	O
,	O
exclusive	O
breastfeeding	O
,	O
low	O
maternal	I:C0243095
vitamin	I:C0243095
D	I:C0243095
level	I:C0243095
,	O
certain	O
medications	O
,	O
drinking	O
unfortified	O
cow	I:C0349374
's	I:C0349374
milk	I:C0349374
,	O
liver	O
failure	I:C0085605
,	O
chronic	O
renal	I:C0403447
insufficiency	I:C0403447
,	O
cystic	O
fibrosis	I:C0010674
,	O
asthma	B:C0004096
,	O
and	O
sickle	O
cell	O
hemoglobinopathy	O
.	O

This	O
review	B:C0282443
highlights	O
and	O
summarizes	O
the	O
molecular	O
perspectives	O
of	O
vitamin	O
D	I:C0042870
deficiency	I:C0042870
and	O
its	O
potential	O
adverse	O
health	O
outcomes	O
in	O
pediatric	O
age	O
groups	O
.	O

This	O
review	O
highlights	O
and	O
summarizes	O
the	O
molecular	O
perspectives	O
of	O
vitamin	B:C0042870
D	I:C0042870
deficiency	I:C0042870
and	O
its	O
potential	O
adverse	O
health	O
outcomes	O
in	O
pediatric	O
age	O
groups	O
.	O

This	O
review	O
highlights	O
and	O
summarizes	O
the	O
molecular	O
perspectives	O
of	O
vitamin	O
D	I:C0042870
deficiency	I:C0042870
and	O
its	O
potential	O
adverse	B:C0879626
health	O
outcomes	O
in	O
pediatric	O
age	O
groups	O
.	O

The	O
recommended	O
treatment	O
regimen	O
is	O
beyond	O
the	O
scope	O
of	O
this	O
review	B:C0282443
.	O

